86 related articles for article (PubMed ID: 26275151)
1. Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda.
Dansereau E; Gakidou E; Ng M; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masters SH; Njuguna P; Odeny TA; Okiro EA; Roberts DA; Duber HC
PLoS One; 2015; 10(8):e0135653. PubMed ID: 26275151
[TBL] [Abstract][Full Text] [Related]
2. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
[TBL] [Abstract][Full Text] [Related]
3. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.
Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J
BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713
[TBL] [Abstract][Full Text] [Related]
4. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C
AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903
[TBL] [Abstract][Full Text] [Related]
5. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
8. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
Duber HC; Dansereau E; Masters SH; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masiye F; Njuguna P; Odeny T; Okiro E; Roberts DA; Gakidou E
PLoS One; 2015; 10(3):e0120350. PubMed ID: 25807553
[TBL] [Abstract][Full Text] [Related]
9. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
[TBL] [Abstract][Full Text] [Related]
10. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
[TBL] [Abstract][Full Text] [Related]
11. No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.
Okoboi S; Ekwaru PJ; Campbell JD; Egessa A; King R; Bakanda C; Muramuzi E; Kaharuza F; Malamba S; Moore DM
BMC Public Health; 2016 Feb; 16():101. PubMed ID: 26830678
[TBL] [Abstract][Full Text] [Related]
12. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
[TBL] [Abstract][Full Text] [Related]
13. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
[TBL] [Abstract][Full Text] [Related]
16. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.
Venkataramani AS; Thirumurthy H; Haberer JE; Ii YB; Siedner MJ; Kembabazi A; Hunt PW; Martin JN; Bangsberg DR; Tsai AC
AIDS; 2014 May; 28(8):1221-6. PubMed ID: 24406678
[TBL] [Abstract][Full Text] [Related]
17. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
[TBL] [Abstract][Full Text] [Related]
18. HIV treatment and monitoring patterns in routine practice: a multi-country retrospective chart review of patient care.
Musa BM; Ibekwe E; Mwale S; Eurien D; Oldenburg C; Chung G; Heller RF
F1000Res; 2018; 7():713. PubMed ID: 30647906
[No Abstract] [Full Text] [Related]
19. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy, CD4, viral load, and disease stage in HIV patients in Saudi Arabia: a 2001-2013 cross-sectional study.
Memish ZA; Al-Tawfiq JA; Filemban SM; Qutb S; Fodail A; Ali B; Darweeish M
J Infect Dev Ctries; 2015 Jul; 9(7):765-9. PubMed ID: 26230128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
